Aurobindo Pharma USA Inc Dicyclomine Hydrochloride Capsules, 10 mg Recall (July 2027)
Announced 2026-08-12 · FDA
Aurobindo Pharma USA Inc is recalling Dicyclomine Hydrochloride Capsules, USP, 10 mg, Rx only. Batch DMC125018A, Exp Date 07/2027, with about 6,408 bottles distributed nationwide in the US. The recall is due to shortfill; reports of empty capsules.
| Brand | Aurobindo Pharma USA Inc |
|---|---|
| Product | Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 |
| Reason | shortfill; reports of empty capsules. |
| Severity | moderate |
| Units affected | 6408 |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Batch # DMC125018A, Exp Date: 07/2027. |
WHAT YOU SHOULD DO
- Do not use any recalled capsules.
- Contact your pharmacy or healthcare provider for guidance on return, refund, or replacement.
- Return or dispose of the recalled product per the pharmacist's or distributor's instructions.
- If you experienced adverse effects, contact your healthcare provider and consider reporting to the FDA MedWatch program.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.